Total revenues:
10.25
Operating profit: -40.249
Operating profit before tax:
-43.124
Total assets: 57.634
Total equity: 14.739
Currency: NOK (all numbers in thousands)
Management
Board Chairman:
Per Edvard Walday
Board Members:
Anders Høgset
Ronny Skuggedal
General Manager:
Per Edvard Walday
Subsidiary companies:
Largest shareholders:
N/A
KEYWORDS
Biomedicine, Medicinal products, Pharmaceutical & Medical Chemical Products, Pharmaceutical & Medicinal Chemicals, Pharmaceutical articles, Research and experimental development services, Terapeutica, Therapeutic agents,